THMO vs. SYRA, AVGR, POAI, HOTH, MGRX, IBIO, CELZ, HSCS, KTRA, and HCTI
Should you be buying ThermoGenesis stock or one of its competitors? The main competitors of ThermoGenesis include Syra Health (SYRA), Avinger (AVGR), Predictive Oncology (POAI), Hoth Therapeutics (HOTH), Mangoceuticals (MGRX), iBio (IBIO), Creative Medical Technology (CELZ), Heart Test Laboratories (HSCS), Kintara Therapeutics (KTRA), and Healthcare Triangle (HCTI). These companies are all part of the "medical" sector.
ThermoGenesis (NASDAQ:THMO) and Syra Health (NASDAQ:SYRA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability, valuation and community ranking.
Syra Health has lower revenue, but higher earnings than ThermoGenesis.
Syra Health has a net margin of 0.00% compared to ThermoGenesis' net margin of -190.31%. Syra Health's return on equity of 0.00% beat ThermoGenesis' return on equity.
5.8% of ThermoGenesis shares are owned by institutional investors. Comparatively, 4.8% of Syra Health shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Comparatively, 10.2% of Syra Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
ThermoGenesis presently has a consensus price target of $5.00, suggesting a potential upside of 614.29%. Given ThermoGenesis' higher possible upside, analysts plainly believe ThermoGenesis is more favorable than Syra Health.
ThermoGenesis received 26 more outperform votes than Syra Health when rated by MarketBeat users.
In the previous week, Syra Health had 9 more articles in the media than ThermoGenesis. MarketBeat recorded 10 mentions for Syra Health and 1 mentions for ThermoGenesis. ThermoGenesis' average media sentiment score of 0.00 beat Syra Health's score of -0.37 indicating that ThermoGenesis is being referred to more favorably in the media.
Summary
ThermoGenesis beats Syra Health on 7 of the 13 factors compared between the two stocks.
Get ThermoGenesis News Delivered to You Automatically
Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding THMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ThermoGenesis Competitors List
Related Companies and Tools
